IM Cannabis Q4 EPS $(0.86) Down From $(0.23) YoY, Sales $11.249M Up From $9.535M YoY
3/31/2026
Impact: -70
Healthcare
IM Cannabis (NASDAQ: IMCC) reported a Q4 loss of $(0.86) per share, a significant increase in losses compared to $(0.23) per share in the same quarter last year, marking a 273.91% decline. However, the company achieved sales of $11.249 million, representing a 17.98% increase from $9.535 million in the previous year.
AI summary, not financial advice
Share: